Healthcare -
Biotechnology - NASDAQ - US
$ 14.24
0.636 %
$ 1.16 B
Market Cap
-4.25
P/E
VRDN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities VRDN - Viridian Therapeutics, Inc.
458 M
LAST VALUE
19.18%
2 YEAR CAGR
479.57%
5 YEAR CAGR
51.06%
10 YEAR CAGR